Antibiotic resistance combined with the ability to persist in hospital environments are 48 responsible for small epidemics of A. baumannii clones. This species exhibits broad intrinsic 49 resistance, mainly conferred by a chromosomally-encoded cephalosporinase, basal level 50 expression of efflux pumps, and a low membrane permeability (66). The most common 51 mechanisms for resistance involve enzymatic degradation of the drugs, modification or 52 protection of the target, and decreased permeability or active efflux of the antibiotics. At the 53 genetic level, resistance is acquired either by horizontal transfer of genetic elements carrying 54 resistance determinants or by mutation in endogenous genes leading to inactivation, 55 modification, or overexpression of cellular functions. Of particular importance are 56 mechanisms leading to multidrug resistance following a single genetic event: (i) horizontal 57 acquisition of an element carrying several resistance genes or (ii) overexpression of a 58 chromosomally-encoded efflux system. Mobile genetic elements, such as plasmids and 59 transposons, are a common feature of multidrug resistance in A. baumannii (19) and 60 resistance islands, i.e. acquired elements inserted in the chromosome and organized in a 61 mosaic structure, have been described to carry as many as 45 resistance genes (18). Although 62 mobility of the latter has not been demonstrated, there is indirect evidence for their 63 dissemination among clinical isolates (60). 64
Efflux-mediated resistance has been reported in many bacterial genera (44, 45) . 65
Overexpression of an efflux system, responsible for reduction in the accumulation of the 66 antibiotic, is an efficient mechanism for drug resistance (44) . Genes encoding these systems 67 on July 6, 2017 by guest http://aac.asm.org/ Downloaded from 6 (67). Evidence for AdeABC-mediated efflux of carbapenems is further suggested by the 118 correlation between overexpression of the adeB gene and resistance level in clinical isolates 119 (28, 34) . A decrease in imipenem MIC in the presence of CCCP was detected against in vitro 120 mutants and clinical strains (27). However, no overexpression of adeB was detected in these 121 strains indicating that, either another system extrudes carbapenems, or that a mutation in 122
AdeABC expands the substrate profile but not the level of expression of the system. Thus, 123
AdeABC overexpression contributes to carbapenem resistance but other efflux mechanisms 124 are also probably involved. Efflux does not itself confer high-level resistance but increases 125 weakly the MICs allowing bacteria to reach high-level resistance when associated with other 126
mechanisms. 127
Upon exposure to NaCl, A. baumannii expresses low-level resistance to carbapenems, 128 aminoglycosides, quinolones, and colistin associated with overexpression of adeA, together 129 with that of other pump genes (25). Osmotic stress could represent a natural inducer for 130 expression of efflux systems. 131
Epidemiology of resistance due to AdeABC. The adeABC operon is present in ca. 80% 132 (from 53% to 97%) of A. baumannii (7, 9, 29, 31, 36, 43, 63) . It has not been found in 32 133 environmental strains (30) and appears to be mainly associated with clinical isolates. A 134 sequence-based typing of adeB has been proposed as an epidemiological tool for clinical 135 strains (30). Correlation between overexpression of adeB and decreased susceptibility to 136 tigecycline was found in 5/40 (12.5%) MDR isolates (7). AdeABC-overexpressing strains 137 have been selected in vivo under treatment by tigecycline (49) and also probably by 138 ciprofloxacin (24); one-step in vitro mutants have been obtained with subinhibitory 139 concentrations of tigecycline (49), moxifloxacin (47), and gentamicin (12, 40) . These data 140 highlight the propensity of A. baumannii to achieve multidrug resistance by overexpression of 141 the pump when exposed to its substrates. Screening for expression of antibiotic resistance 142 AdeIJK. AdeIJK, encoded by the adeIJK operon (Fig. 1) , is the second RND efflux 187 system described in A. baumannii (14). This pump is specific for the species (36, 55) where it 188 contributes to intrinsic resistance to β-lactams, such as ticarcillin, cephalosporins and 189 aztreonam, fluoroquinolones, tetracyclines, tigecycline, lincosamides, rifampin, 190 chloramphenicol, co-trimoxazole, novobiocin, and fusidic acid (Table 1) anaerobes (51). In A. baumannii, tigecycline is a substrate for the three characterized RND 231 pumps described above (13, 14) . AdeABC is, however, the only system to date to have been 232 involved in resistance of clinical isolates (26, 48, 58, 59) . Ruzin et al. showed that, among a 233 collection of 106 A. baumannii, overexpression of AdeABC is a prevalent mechanism for 234 decreased susceptibility to tigecycline and reported a linear relationship between log-235 transformed adeA expression and tigecycline MIC in the range of 0.5 to 16 µg/ml (58). 236
Increase in the MIC of tigecycline without expression of adeA has also been reported, 237 indicating the involvement of another mechanism (58). 238 RND systems and non-antibiotic compounds. As already mentioned, RND efflux 239 systems typically exhibit wide substrate ranges. AdeABC and AdeIJK extrude, in addition to 240 antibiotics, several biocides, detergents, antiseptics, and dyes (14, 38, 55) . AdeFGH is able to 241 export SDS, acridine orange, safranine O, and ethidium bromide (13). 242 
Non-RND efflux systems 250
CraA. CraA (for chloramphenicol resistance Acinetobacter) is homologous to the 251
MdfA efflux pump of E. coli that extrudes only chloramphenicol (57). Inactivation of CraA in 252
A. baumannii results in a 128-fold decrease in chloramphenicol resistance. The system has 253 been found in all 82 A. baumannii tested and is believed to contribute to intrinsic resistance to 254 chloramphenicol but it is not known if it is constitutively expressed or confers resistance only 255 after overexpression. The structural gene for the pump, together with other efflux genes, has 256 been found overexpressed in response to exposure to NaCl (25). 
CHROMOSOMALLY-ENCODED EFFLUX SYSTEMS IN OTHER 277 ACINETOBACTER SPP. 278
The Acinetobacter genus comprises a minimum of 21 defined species (5). To date, 279 studies have focused mainly on the sequenced strains Acinetobacter baylyi ADP1 and 280
Acinetobacter genomic DNA group 3 (GDG 3), a species frequently associated with hospital-281 acquired infections in Southeast Asia. 282
AdeXYZ. An efflux system, AdeXYZ, which shares more than 97% identity with 283 AdeIJK (14) has been found in Acinetobacter GDG 3 (10). This pump is present in ca. 90% of 284 the strains of the species. Attempts to disrupt the adeY gene failed but the homology with 285
AdeIJK suggests that it could have a similar function, i.e. intrinsic resistance and probable 286 acquisition of higher levels of resistance by overexpression. AdeX, Y, and Z share 80, 89, and 287 87% amino acid identity, respectively, with the MFP, RND, and OMF proteins of an efflux 288 system from A. baylyi ADP1 (10) which has been shown to contribute to intrinsic resistance 289 of the species to β-lactams, ciprofloxacin, tetracycline, rifampin, and chloramphenicol (20) found downstream from the adeDE gene cluster, suggesting that another outer membrane 295 protein could be recruited to form a tripartite efflux pump. The AdeDE system, which 296 displays less than 45% identity with AdeAB, extrudes aminoglycosides, carbapenems, 297 ceftazidime, fluoroquinolones, erythromycin, tetracycline, rifampin, and chloramphenicol (8). 298
Inactivation of adeE in a clinical isolate leads to a greater than four-fold increased 299 susceptibility to these antibiotics. The adeE gene was found in ca. 70% of Acinetobacter 300 GDG 3 strains, in one Acinetobacter GDG 13TU, and one Acinetobacter GDG 17 (10). 
